Diffusion newsletters

May 31, 2024 World No Tobacco Day PRESS RELEASE EVERY YEAR, TOBACCO CAUSES 45.000 DEATHS AND MAKES 226.000 PEOPLE ILL IN ARGENTINA The consumption of cigarettes and other tobacco products in Argentina causes, every year, approximately 45.000 deaths and more than 226.000 new cases of illness, which implies losses of more than 5.300 […]

May 17, 2023 PRESS RELEASE ARGENTINE SCIENTISTS PROPOSE IN THE LANCET A GLOBAL EQUATION FOR THE MORE EQUITABLE ALLOCATION OF HEALTH RESOURCES TOGETHER WITH A COLLEAGUE FROM THE UNITED KINGDOM, RESEARCHERS FROM THE INSTITUTE OF CLINICAL AND HEALTH EFFECTIVENESS (IECS) FORMULATED A NOVEL, SIMPLE AND DIRECT EQUATION THAT CAN HELP HEALTH SYSTEMS IN THE UNITED KINGDOM.

03 April 2023 PRESS RELEASE WE SUPPORT THE RESTRICTIONS ON HEATED TOBACCO PRODUCTS The Ministry of Health of the Nation, through resolution 565/2023– resolved to prohibit the importation, distribution, marketing, advertising and any form of promotion and sponsorship of the so-called “heated tobacco products”. From the IECS we celebrate this measure, which constitutes a

March 30, 2023 NEWSLETTER AN ARGENTINE OBSTETRIST DOCTOR WINS PRESTIGIOUS CANADIAN AWARD WHICH LELOIR AND MILSTEIN ALSO RECEIVED An Argentine obstetrician and researcher, the Dr. José Belizan, has been awarded Canada's prestigious 2023 Gairdner International Prize in the Global Health category, “awarded to science-based research that has improved health and

March 4. World Obesity Day GACETILLA ARGENTINA: THE EFFECTIVE APPLICATION OF THE “LABELING LAW” WILL PREVENT MORE THAN 100.000 CASES OF OVERWEIGHT AND OBESITY IN GIRLS, BOYS AND ADOLESCENTS A NEW STUDY PROJECTS THE IMPACT OF THE STANDARD IN THE SHORT AND LONG TERM , INCLUDING THOUSANDS OF CASES OF DISEASES

March 4. World Obesity Day GACETILLA 4,3 MILLION CASES OF EXCESS WEIGHT AND OBESITY ARE ATTRIBUTABLE TO THE CONSUMPTION OF SUGARY DRINKS STUDY CONDUCTED IN 4 COUNTRIES IN LATIN AMERICA AND THE CARIBBEAN WARNS THAT THE CONSUMPTION OF SUGARY DRINKS IS ASSOCIATED WITH OBESITY AND OVERWEIGHT. IT ALSO NOTES THAT U$D IS SPENT

January 2022 COVID-19 GAZETTE: THE MOST COMPREHENSIVE ANALYSIS OF CLINICAL TRIALS WORLDWIDE, IN WHICH 2 ARGENTINES PARTICIPATED, CONFIRMED THE EFFICACY AND SAFETY OF THE VACCINES THE STUDY RATES THE BENEFIT OF THE VACCINES AS “INDISCUTABLE” AND POINTS OUT THAT THE RNA VACCINES MESSENGER (MADE BY PFIZER/BIONTECH AND MODERN) WOULD BE MORE EFFECTIVE IN PREVENTING